All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Novartis
Huningue
Scandal
Tele
Note of
Scandal
Beovu
Novartis
Scandal
Usine Buitoni
Mln
Scandal
Konya Wa Pizza Party
Robert Morris Ministry
Scandal
Ravi Zacharias
Scandal 2020
Greece
Scandal
Novartis
News
Boracay
Scandal
Novartis
Pharmaceuticals
Novartis
Settlement
Alcon
Novartis
NHK News Today
Archana Sharma
Scandal
Scientist Brothers
Kouloglou
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Novartis
Huningue
Scandal
Tele
Note of
Scandal
Beovu
Novartis
Scandal
Usine Buitoni
Mln
Scandal
Konya Wa Pizza Party
Robert Morris Ministry
Scandal
Ravi Zacharias
Scandal 2020
Greece
Scandal
Novartis
News
Boracay
Scandal
Novartis
Pharmaceuticals
Novartis
Settlement
Alcon
Novartis
NHK News Today
Archana Sharma
Scandal
Scientist Brothers
Kouloglou
2:01
Novartis reviews business but not rewards
Jan 29, 2014
NY Times
The New York Times
News | Novartis
Apr 22, 2012
novartis.com
Cardiovascular Disease | Novartis United States of America
3 months ago
novartis.com
Corporate responsibility | Novartis United States of America
Jul 21, 2022
novartis.com
1:52
Our CEO, Vas Narasimhan, shares his vision for Novartis’ future as a more focused medicines company. http://bit.ly/2Vw8PDf | Novartis
11.3K views
Apr 9, 2019
Facebook
Novartis
Novartis Scandal: Former Protected Witnesses Face Criminal Prosecution | Pagenews.gr
Jan 21, 2025
pagenews.gr
Incyte, Novartis Pharma Reach Settlement Over Jakafi Royalties
May 14, 2025
marketscreener.com
Novartis cannot block generic of best-selling heart drug, US appeals court says
Dec 4, 2024
marketscreener.com
7:11
Fighting Fake Medicines | Novartis’ Digital Tools Against Counterfeits
Jun 4, 2020
novartis.com
2:29
Niederlage für Novartis
Apr 1, 2013
SRF
5:56
Niederlage für Novartis
Apr 1, 2013
SRF
0:14
Matthias and Tobias are Novartis scientists running for transplant patients. They bring our Commitment to Patients and Caregivers to life. | Novartis
59.5K views
Feb 19, 2019
Facebook
Novartis
Novartis and UC Berkeley take on “undruggable” proteins in new collaboration
Oct 5, 2021
novartis.com
Novartis: Breaking Barriers for Health Equity
Sep 12, 2023
reuters.com
4:42
MSN
Feb 17, 2025
MSN
CNBC
4:24
Novartis earnings edge higher in Q1, CEO breaks down quarter
Apr 26, 2022
CNBC
1:14
Novartis CEO says FDA's extended approval of breast cancer drug is a 'landmark' for the firm
Sep 28, 2024
MSN
CNBC
4:18
Focus remains on R&D to drive growth of blockbuster drugs, says Novartis CEO
Oct 30, 2024
MSN
CNBC
Novartis is considering further acquisitions to drive growth, CEO says
Jan 31, 2025
MSN
CNBC
4:45
Novartis CEO on earnings: Launch drivers like breast cancer, MS medicines are performing really well
Apr 29, 2025
MSN
CNBC
0:17
When we innovate using the latest technology, we work to turn science fiction into science fact. | Novartis
283.1K views
May 23, 2019
Facebook
Novartis
4:14
Novartis CEO talks about new cancer therapy programs
Jun 7, 2021
CNBC
6:41
Watch CNBC's full interview with Novartis' Vas Narasimhan
1 month ago
CNBC
Elsa Ohlen
Novartis Sets High Bar in Pursuit of Obesity Deals, CEO Says
Feb 4, 2025
wsj.com
7:37
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Apr 28, 2020
CNBC
Novartis posts better-than-expected first-quarter sales, raises full-year guidance
Apr 29, 2025
NBC New York
Karen Gilchrist
3:28
Novartis generated $40 billion in innovative medicine sales, says CEO
Jan 10, 2023
CNBC
7:27
Novartis CEO on company's approach to Covid-19 treatment
Jul 21, 2020
CNBC
4:25
Novartis CEO: We're never done with M&A
6 months ago
CNBC
Carolin Roth
5:52
Novartis expects 'strong momentum' going into second half, says CEO Vasant Narasimhan
Jul 18, 2024
CNBC
See more
More like this
Feedback